Carissa Wong via New Scientist:

‘A landmark trial showed that a single dose of the psychedelic drug eased the mental health condition without severe or lasting side effects. “It’s a milestone,” says Greg Cooper at University College London, who wasn’t involved in the trial. “It looks fairly likely that approval from the US Food and Drug Administration will happen in the next year or two,” he says. “That would set a precedent for approval elsewhere, such as the UK and Europe.”…’